May 25, 2007Diabetes Care
Waist Circumference and Cardiometabolic Risk
Key result
Waist circumferences greater than 40 inches in men and 35 inches in women are considered surrogate markers of abdominal fat mass associated with increased cardiometabolic disease risk.
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
BMI-mortality link in cardiometabolic disease remains observational; leaves open refined thresholds for modern populations.
Key Points
- This research examines the role of waist circumference in assessing the risk of cardiometabolic diseases associated with obesity.
- Analyzed data from epidemiological studies correlating waist circumference and abdominal fat to cardiometabolic disease risk.
- Defined cut points for increased risk based on waist circumference measurements in men and women.
- Waist circumference thresholds of >40 inches for men and >35 inches for women indicate increased cardiometabolic risk.
- Abdominal fat measurement through waist circumference shows a strong correlation with overall health outcomes.
PICO
P
Population
Cardiometabolic disease
E
Exposure / Comparator
Waist circumference
Waist circumference is an important surrogate marker for abdominal fat mass and is associated with increased cardiometabolic disease risk.
Cite This Study
Klein et al. (2007) conducted a review in Cardiometabolic disease. Waist circumference was evaluated. Waist circumferences greater than 40 inches in men and 35 inches in women are considered surrogate markers of abdominal fat mass associated with increased cardiometabolic disease risk.